Mark R. Davies

Global dissemination of a multidrug resistant <i>Escherichia coli</i> clone

Nicola K. Petty, Nouri L. Ben Zakour, Mitchell Stanton‐Cook et al. · Proceedings of the National Academy of Sciences · 2014 · 559 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline

Violette Da Cunha, Mark R. Davies, Pierre-Emmanuel Douarre et al. · Nature Communications · 2014 · 249 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes

John A. Lees, Minna Vehkala, Niko Välimäki et al. · Nature Communications · 2016 · 224 citations · Full text

Life Sciences, Bioinformatics, Microbiology +16

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

Mark R. Davies, Liam McIntyre, Ankur Mutreja et al. · Nature Genetics · 2019 · 211 citations · Full text

Life Sciences, Bioinformatics, Microbiology +14

Protection against Group A Streptococcus by Immunization with J8–Diphtheria Toxoid: Contribution of J8‐ and Diphtheria Toxoid–Specific Antibodies to Protection

Michael R. Batzloff, Wendy A. Hayman, Mark R. Davies et al. · The Journal of Infectious Diseases · 2003 · 193 citations · Full text

Life Sciences, Immunology, Microbiology +17